首页 | 本学科首页   官方微博 | 高级检索  
     

右美托咪定预处理对肝癌切除手术患者的肝缺血再灌注损伤的价值
引用本文:朱丽,张敬梅,赵亮. 右美托咪定预处理对肝癌切除手术患者的肝缺血再灌注损伤的价值[J]. 临床和实验医学杂志, 2021, 20(5): 518-522
作者姓名:朱丽  张敬梅  赵亮
作者单位:辽宁省朝阳市第二医院 麻醉科 辽宁 朝阳 122000;辽宁省朝阳市第二医院 止痛科 辽宁 朝阳 122000;辽宁省锦州市中心医院麻醉科 辽宁 锦州 121001
基金项目:辽宁省自然科学基金(编号:201700325L)。
摘    要:目的 探讨右美托咪定(Dex)预处理对于肝癌切除手术患者的肝缺血再灌注损伤的影响.方法 前瞻性选取辽宁省朝阳市第二医院拟实施半肝切除手术治疗的95例原发性肝细胞癌患者作为研究对象,采用随机数字表法分为预处理组48例和常规组47例,预处理组手术前给予Dex 0.7μg/kg,10 min内输注完毕,后以0.4μg/(kg...

关 键 词:原发性肝细胞癌  半肝切除  右美托咪定  预处理  缺血再灌注损伤

Value of dexmedetomidine preconditioning on hepatic ischemia-reperfusion injury in patients undergoing hepatectomy for liver cancer
ZHU Li,ZHANG Jing-mei,ZHAO Liang. Value of dexmedetomidine preconditioning on hepatic ischemia-reperfusion injury in patients undergoing hepatectomy for liver cancer[J]. Journal of Clinical and Experimental Medicine, 2021, 20(5): 518-522
Authors:ZHU Li  ZHANG Jing-mei  ZHAO Liang
Affiliation:(Department of Anesthesiology,Second Hospital of Chaoyang City Liaoning Province,Chaoyang Liaoning 122000,China;Department of Analgesia,Second Hospital of Chaoyang City Liaoning Province,Chaoyang Liaoning 122000,China;Department of Anesthesiology,Jinzhou Central Hospital,Jinzhou Liaoning 121001,China)
Abstract:Objective To explore the effect of dexmedetomidine(Dex) pretreatment on liver ischemia-reperfusion injury in patients undergoing liver cancer resection. Methods Ninety-five patients undergoing hemihepatectomy in the Second Hospital of Chaoyang City Liaoning Province were prospectively selected as the research objects,and they were divided into the pretreatment group using a random number table method 48 cases and 47 cases in the conventional group. the pretreatment group was given Dex 0. 7 μg/kg before the operation,the infusion was completed within 10 minutes,and 0. 4 μg/(kg·h) maintained until the end of the operation,the conventional group was given the same amount of normal saline. The operation time,intraoperative blood loss,blood transfusion rate,hepatic blood flow block time,and surgical complications were compared between the two groups. The serum alanine transaminase(ALT),aspartic transaminase(AST),glutamyl transpeptidase(GGT),total bilirubin(STB),conjugated bilirubin(CB),malondialdehyde(MDA),superoxide dismutase(SOD),tumor necrosis factor-α(TNF-α),C-reactive protein(CRP),high mobility group protein B1(HMGB1),interleukin-6(IL-6) before and 24 hours after the operation were compared between the two groups of patients were compared. Results There was no statistically significant difference in the operation time,intraoperative blood loss,blood transfusion rate,and hepatic blood flow block time between the two groups of patients(P > 0. 05). Before operation,the serum ALT,AST,GGT,STB,CB test values of the pretreatment group and the routine group were compared,and there was no significant difference(P > 0. 05);24 h after the operation,the ALT,AST,GGT,STB,CB of the pretreatment group were(330. 2 ± 104. 0) U/L,(367. 1 ±110. 8) U/L,(31. 75 ± 7. 25) U/L,(65. 20 ± 11. 35) μmol/L,(37. 67 ± 6. 29) μmol/L,which were lower than the conventional group[(418. 6 ± 120. 7) U/L,(440. 8 ± 127. 6) U/L,(38. 00 ± 9. 52) U/L,(74. 18 ± 13. 37) μmol/L,(42. 52 ± 8. 06) μmol/L],the differences were statistically significant(P < 0. 05). Before surgery,there was no statistically significant difference in levels of serum MDA,SOD,TNF-α,CRP,HMGB1 and IL-6 between the pretreatment group and the routine group(P > 0. 05). 24 h after the operation,the levels of serum MDA,TNF-α,CRP,HMGB1,IL-6 were(4. 36 ± 1. 33) μmol/L,(5. 20 ± 1. 64) μg/L,(34. 75 ± 6. 83) mg/L,(258. 4 ± 41. 7)μg/L,(31. 28 ± 9. 50) μg/L,which were lower than the conventional group[(5. 11 ± 1. 57) μmol/L,(7. 00 ± 2. 17) μg/L,(43. 80 ± 8. 53)mg/L,(295. 0 ± 46. 4) μg/L,(48. 64 ± 11. 57) μg/L](P < 0. 05),the level of serum SOD [(126. 9 ± 25. 0) U/L] of the pretreatment group was higher than that of the routine group [(113. 1 ± 19. 6) U/L],the differences were statistically significant(P < 0. 05). The surgical complication rate of the pretreatment group(12. 50%) compared with the routine group(21. 28%),the difference was not statistically significant(P > 0. 05). Conclusion Dex pretreatment can significantly reduce liver ischemia-reperfusion injury and protect liver function.
Keywords:Primary hepatocellular carcinoma  Hepatic resection  Dexmedetomidine  Preconditioning  Ischemia-reperfusion injury
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号